Table 1.
Serum PRNT50 titers at day 35 of all animals against ZIKV, DENV2, and WNV.
| Experiment 1a | Animal ID | ZIKV PRNT50 | DENV2 PRNT50 | WNV PRNT50 | Experiment 2b | Animal ID | ZIKV PRNT50 | DENV2 PRNT50 | WNV PRNT50 |
|---|---|---|---|---|---|---|---|---|---|
| Vaccinees | 710 | 5,242 | 134 | < 20 | Vaccinees | 6,749 | 4,558 | 65 | 24 |
| 720 | 40,446 | 1,186 | 392 | C29573 | 4,632 | 106 | < 20 | ||
| 724 | 48 | < 20 | < 20 | C30730 | 2,420 | 71 | 59 | ||
| 728 | 4,866 | 118 | 30 | 6,751 | 2,406 | 201 | 24 | ||
| Controls | 714 | < 40 | < 20 | < 20 | Controls | 6,750 | < 40 | < 20 | < 20 |
| 715 | < 40 | < 20 | < 20 | 6,752 | < 40 | < 20 | < 20 | ||
| 716 | < 40 | < 20 | < 20 | 6,739 | < 40 | < 20 | < 20 | ||
| 723 | < 40 | < 20 | < 20 | 6,744 | < 40 | < 20 | < 20 |
a
Vaccine recipients in experiment 1 received ZIKV E with CoVaccine HT™.
b
Vaccine recipients in experiment 2 received ZIKV E with Alhydrogel® 85.